17 Jul 2025

Assessing Critical Quality Attributes of Viral Vectors - ARTICLE

Intertek
Assessing Critical Quality Attributes of Viral Vectors - ARTICLE
Explore the latest analytical strategies for AAV characterisation and learn how to optimise your viral vector development
Mark Redfern - Cell and Gene Therapy Team Leader, Intertek Pharmaceutical Services, describes key considerations for the characterization of viral vectors
The inherent complexity of viral vector-based products makes their physical and biological characterization highly challenging. From a regulatory perspective, an understanding of viral vector critical quality attributes that impact product safety, purity, and potency, mean that specific, robust analytical assays are needed. read the full article now to deepen your understanding of regulatory expectations and quality attributes.
 
Explore the latest analytical strategies for AAV characterisation and learn how to optimise your viral vector development — read the full article now >
 
 
Discover more:
 
 
 
 
Questions?
TEL: +44 (0)116 296 1620  
EMAIL: pharma.services@intertek.com
View all Exhibitor New & Articles
Loading